Current Reviews In Clinical And Experimental Pharmacology
期刊中文名：臨床和實(shí)驗(yàn)藥理學(xué)最新評(píng)論ISSN：2772-4328E-ISSN：2772-4336
該雜志國(guó)際簡(jiǎn)稱：CURR REV CLIN EXP PH，是由出版商Bentham出版的一本致力于發(fā)布--研究新成果的的專業(yè)學(xué)術(shù)期刊。主要發(fā)表刊登有創(chuàng)見(jiàn)的學(xué)術(shù)論文文章、行業(yè)最新科研成果，扼要報(bào)道階段性研究成果和重要研究工作的最新進(jìn)展，選載對(duì)學(xué)科發(fā)展起指導(dǎo)作用的綜述與專論，促進(jìn)學(xué)術(shù)發(fā)展，為廣大讀者服務(wù)。該刊是一本國(guó)際優(yōu)秀雜志，在國(guó)際上有很高的學(xué)術(shù)影響力。
雜志介紹
Current Reviews In Clinical And Experimental Pharmacology雜志介紹
《Current Reviews In Clinical And Experimental Pharmacology》是一本以English為主的未開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱臨床和實(shí)驗(yàn)藥理學(xué)最新評(píng)論，本刊主要出版、報(bào)道領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為1.3，最新CiteScore 指數(shù)為4.8。
英文介紹
Current Reviews In Clinical And Experimental Pharmacology雜志英文介紹
Current Reviews in Clinical and Experimental Pharmacology is a peer-reviewed journal dedicated to the field of clinical and experimental pharmacology. This magazine aims to provide a platform for publishing review articles on drug mechanisms of action, pharmacodynamics, pharmacokinetics, drug therapy, and new drug development. It covers a wide range of topics from basic research to clinical applications, aiming to promote scientific exchange and knowledge updates in the field of pharmacology. The characteristic of a journal is its comprehensive review of the latest research findings, which is typically based on extensive literature reviews and provides in-depth analysis of specific drug categories or therapeutic fields. This form of article is highly valuable for researchers, clinical doctors, and students as it can help readers quickly grasp the current research status and future directions in a particular field.
The editorial team of the magazine is composed of experienced pharmacologists who ensure that the published articles have high academic standards and practical application value. In addition, journals may regularly invite leading figures in the field to write invited reviews to further enhance their influence in the academic community. It is an important academic resource dedicated to promoting the development of clinical and experimental pharmacology, suitable for professionals seeking in-depth understanding of the latest developments in drug research to read and reference.
JCR分區(qū)（2023-2024年最新版）
Current Reviews In Clinical And Experimental Pharmacology雜志 JCR分區(qū)信息
| 按JIF指標(biāo)學(xué)科分區(qū) |
學(xué)科：PHARMACOLOGY & PHARMACY
收錄子集：ESCI
分區(qū)：Q4
排名：283 / 354
百分位：
20.2% |
| 按JCI指標(biāo)學(xué)科分區(qū) |
學(xué)科：PHARMACOLOGY & PHARMACY
收錄子集：ESCI
分區(qū)：Q4
排名：267 / 354
百分位：
24.72% |
JCR分區(qū)：JCR分區(qū)來(lái)自科睿唯安公司,JCR是一個(gè)獨(dú)特的多學(xué)科期刊評(píng)價(jià)工具，為唯一提供基于引文數(shù)據(jù)的統(tǒng)計(jì)信息的期刊評(píng)價(jià)資源。每年發(fā)布的JCR分區(qū)，設(shè)置了254個(gè)具體學(xué)科。JCR分區(qū)根據(jù)每個(gè)學(xué)科分類按照期刊當(dāng)年的影響因子高低將期刊平均分為4個(gè)區(qū)，分別為Q1、Q2、Q3和Q4，各占25%。JCR分區(qū)中期刊的數(shù)量是均勻分為四個(gè)部分的。
CiteScore 評(píng)價(jià)數(shù)據(jù)（2024年最新版）
Current Reviews In Clinical And Experimental Pharmacology雜志CiteScore 評(píng)價(jià)數(shù)據(jù)
- CiteScore 值：4.8
- SJR：0.44
- SNIP：0.647
| 學(xué)科類別 | 分區(qū) | 排名 | 百分位 |
| 大類：Pharmacology, Toxicology and Pharmaceutics 小類：General Pharmacology, Toxicology and Pharmaceutics | Q1 | 14 / 80 |
83% |
| 大類：Pharmacology, Toxicology and Pharmaceutics 小類：Pharmacology (medical) | Q2 | 106 / 272 |
61% |
歷年影響因子和期刊自引率
投稿經(jīng)驗(yàn)
Current Reviews In Clinical And Experimental Pharmacology雜志投稿經(jīng)驗(yàn)
該雜志是一本國(guó)際優(yōu)秀雜志，在國(guó)際上有較高的學(xué)術(shù)影響力，行業(yè)關(guān)注度很高，已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，該雜志在綜合專業(yè)領(lǐng)域?qū)I(yè)度認(rèn)可很高，對(duì)稿件內(nèi)容的創(chuàng)新性和學(xué)術(shù)性要求很高，作為一本國(guó)際優(yōu)秀雜志，一般投稿過(guò)審時(shí)間都較長(zhǎng)，投稿過(guò)審時(shí)間平均 ，如果想投稿該刊要做好時(shí)間安排。版面費(fèi)不祥。該雜志近兩年未被列入預(yù)警名單，建議您投稿。如您想了解更多投稿政策及投稿方案，請(qǐng)咨詢客服。
免責(zé)聲明
若用戶需要出版服務(wù)，請(qǐng)聯(lián)系出版商。